Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0166 Transporter Info | ||||
Gene Name | SLC24A5 | ||||
Transporter Name | Sodium/potassium/calcium exchanger 5 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Bladder cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg09456905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.93E+00 | Statistic Test | p-value: 2.58E-08; Z-score: -1.16E+01 | ||
Methylation in Case |
3.60E-01 (Median) | Methylation in Control | 6.94E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg24125468) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.31E+00 | Statistic Test | p-value: 5.24E-08; Z-score: -6.95E+00 | ||
Methylation in Case |
2.99E-01 (Median) | Methylation in Control | 6.89E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
TSS200 (cg19409156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 5.29E-09; Z-score: -1.18E+01 | ||
Methylation in Case |
6.60E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
TSS200 (cg01325409) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.33E+00 | Statistic Test | p-value: 5.61E-08; Z-score: -6.85E+00 | ||
Methylation in Case |
2.72E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
TSS200 (cg09625274) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 9.37E-08; Z-score: -7.30E+00 | ||
Methylation in Case |
5.90E-01 (Median) | Methylation in Control | 7.85E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
1stExon (cg04643655) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.15E+00 | Statistic Test | p-value: 1.72E-05; Z-score: -8.56E+00 | ||
Methylation in Case |
2.25E-01 (Median) | Methylation in Control | 4.84E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
Body (cg08411738) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 6.97E-05; Z-score: -8.91E+00 | ||
Methylation in Case |
7.91E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
Body (cg13223777) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.13E-04; Z-score: -1.62E+01 | ||
Methylation in Case |
7.07E-01 (Median) | Methylation in Control | 8.92E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC24A5 in bladder cancer | [ 1 ] | |||
Location |
Body (cg18585464) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.17E-04; Z-score: -3.26E+00 | ||
Methylation in Case |
8.70E-01 (Median) | Methylation in Control | 9.22E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg24125468) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 7.84E-05; Z-score: -1.13E+00 | ||
Methylation in Case |
6.82E-01 (Median) | Methylation in Control | 7.47E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg09456905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 2.73E-02; Z-score: -4.19E-01 | ||
Methylation in Case |
5.73E-01 (Median) | Methylation in Control | 6.25E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg01325409) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 1.01E-07; Z-score: -1.55E+00 | ||
Methylation in Case |
5.16E-01 (Median) | Methylation in Control | 6.01E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg09625274) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 9.65E-04; Z-score: -8.21E-01 | ||
Methylation in Case |
7.26E-01 (Median) | Methylation in Control | 7.70E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg19409156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 4.47E-03; Z-score: -5.44E-01 | ||
Methylation in Case |
8.28E-01 (Median) | Methylation in Control | 8.53E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
1stExon (cg04643655) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 3.88E-03; Z-score: -1.09E+00 | ||
Methylation in Case |
4.05E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC24A5 in breast cancer | [ 2 ] | |||
Location |
Body (cg13223777) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.97E-03; Z-score: -8.99E-01 | ||
Methylation in Case |
8.45E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
TSS1500 (cg09456905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 3.07E-10; Z-score: -2.20E+00 | ||
Methylation in Case |
6.41E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
TSS1500 (cg24125468) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 7.59E-10; Z-score: -3.23E+00 | ||
Methylation in Case |
8.31E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
TSS200 (cg01325409) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.34E+00 | Statistic Test | p-value: 6.86E-17; Z-score: -5.70E+00 | ||
Methylation in Case |
5.94E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
TSS200 (cg19409156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.62E-04; Z-score: -1.93E+00 | ||
Methylation in Case |
9.20E-01 (Median) | Methylation in Control | 9.36E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
TSS200 (cg09625274) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.55E-04; Z-score: -1.54E+00 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 9.23E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
1stExon (cg04643655) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 1.55E-12; Z-score: -2.84E+00 | ||
Methylation in Case |
5.52E-01 (Median) | Methylation in Control | 6.71E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg13223777) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 9.89E-05; Z-score: -8.90E-01 | ||
Methylation in Case |
9.25E-01 (Median) | Methylation in Control | 9.38E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg18242760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.86E-03; Z-score: -1.59E+00 | ||
Methylation in Case |
9.39E-01 (Median) | Methylation in Control | 9.49E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg08411738) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.42E-02; Z-score: -6.29E-01 | ||
Methylation in Case |
9.15E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC24A5 in colorectal cancer | [ 3 ] | |||
Location |
Body (cg18585464) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.90E-02; Z-score: -2.53E-01 | ||
Methylation in Case |
9.42E-01 (Median) | Methylation in Control | 9.46E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg04344565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.54E+00 | Statistic Test | p-value: 3.17E-16; Z-score: 4.64E+00 | ||
Methylation in Case |
3.16E-01 (Median) | Methylation in Control | 6.95E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in lung adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg09456905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 7.32E-03; Z-score: 1.60E+00 | ||
Methylation in Case |
6.80E-01 (Median) | Methylation in Control | 6.21E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in panic disorder | [ 6 ] | |||
Location |
TSS1500 (cg24125468) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 6.07E-03; Z-score: 7.32E-01 | ||
Methylation in Case |
1.35E+00 (Median) | Methylation in Control | 1.07E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC24A5 in panic disorder | [ 6 ] | |||
Location |
TSS1500 (cg09456905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -8.35E-01 | Statistic Test | p-value: 4.86E-02; Z-score: -2.78E-01 | ||
Methylation in Case |
-5.65E-01 (Median) | Methylation in Control | -4.71E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC24A5 in panic disorder | [ 6 ] | |||
Location |
Body (cg18242760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.85E-05; Z-score: -5.20E-01 | ||
Methylation in Case |
2.14E+00 (Median) | Methylation in Control | 2.34E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg04237663) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.21E+00 | Statistic Test | p-value: 2.11E-28; Z-score: 6.95E+00 | ||
Methylation in Case |
2.29E-01 (Median) | Methylation in Control | 7.13E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg00068153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.25E-07; Z-score: -2.63E-01 | ||
Methylation in Case |
8.67E-01 (Median) | Methylation in Control | 8.71E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg19062099) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 5.64E-05; Z-score: -1.10E+00 | ||
Methylation in Case |
4.98E-01 (Median) | Methylation in Control | 5.70E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg00031491) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 6.67E-04; Z-score: 1.12E+00 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg19117698) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 6.77E-04; Z-score: 8.50E-01 | ||
Methylation in Case |
7.52E-01 (Median) | Methylation in Control | 7.25E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg03426615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 8.08E-04; Z-score: -5.42E-01 | ||
Methylation in Case |
8.50E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC24A5 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg09357268) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.07E-02; Z-score: 6.05E-01 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC24A5 in papillary thyroid cancer | [ 8 ] | |||
Location |
TSS200 (cg19409156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 9.12E-03; Z-score: 5.94E-01 | ||
Methylation in Case |
9.25E-01 (Median) | Methylation in Control | 9.13E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC24A5 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg13223777) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.41E-03; Z-score: -8.67E-01 | ||
Methylation in Case |
9.24E-01 (Median) | Methylation in Control | 9.35E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC24A5 in papillary thyroid cancer | [ 8 ] | |||
Location |
Body (cg18585464) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.08E-02; Z-score: -4.52E-01 | ||
Methylation in Case |
9.36E-01 (Median) | Methylation in Control | 9.44E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Liver cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate/significant hypermethylation of SLC24A5 in liver cancer than that in healthy individual/adjacent tissue | ||||
Studied Phenotype |
Liver cancer [ICD-11:2C12] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.014021521; Fold-change: -0.28568804; Z-score: -0.919731226 | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value: 1.10E-15; Fold-change: -0.324515793; Z-score: -5.897492375 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Medulloblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC24A5 in medulloblastoma than that in healthy individual | ||||
Studied Phenotype |
Medulloblastoma [ICD-11:2A00.10] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 8.53E-12; Fold-change: -0.209002525; Z-score: -0.996259881 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Multilayered rosettes embryonal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypomethylation of SLC24A5 in multilayered rosettes embryonal tumour than that in healthy individual | ||||
Studied Phenotype |
Multilayered rosettes embryonal tumour [ICD-11:2A00.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.78E-13; Fold-change: -0.200803011; Z-score: -1.875085476 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC24A5 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 4.02E-13; Fold-change: -0.37617859; Z-score: -3.292267046 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC24A5 in melanocytoma than that in healthy individual | ||||
Studied Phenotype |
Melanocytoma [ICD-11:2F36.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.56E-20; Fold-change: -0.604165624; Z-score: -8.515650337 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC24A5 in melanoma than that in healthy individual | ||||
Studied Phenotype |
Melanoma [ICD-11:2C30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 6.98E-07; Fold-change: -0.412492001; Z-score: -3.400358984 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Pancreatic cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypomethylation of SLC24A5 in pancreatic adenocarcinoma than that in healthy individual | ||||
Studied Phenotype |
Pancreatic cancer [ICD-11:2C10] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.016452696; Fold-change: -0.376039048; Z-score: -1.813626259 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.